The FDA has issued draft guidances that should ease the way for more generic drugs.
Christine Blank, Contributing Editor
Dual antithrombotic therapy using dabigatran significantly reduces risk of bleeding compared to triple therapy using warfarin.
The risk of intraocular bleeding was reduced by one-fifth when using newer anticoagulants versus warfarin in a new study.
CVS Health executives are pleased that a lawsuit alleging collusion with PBMS on generic drug costs has been withdrawn.
A California bill aimed at curbing drug prices is about to be signed, despite concerns it will raise generic drug prices.
Rivaroxaban (Xarelto, Janssen/ Bayer) has been found to significantly reduce the risk of strokes and heart attacks in patients with artery disease.
Senate passes FDARA overwhelmingly, ahead of September deadline.
Generic drugs make up 90% of prescriptions.
Savings from generic and biosimilar drugs are making PBMs and pharmacies, as well as patients, happy.
Pharmacy chains are forcing lower generic prices for their customers.